Trade CV stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
CapsoVision, Inc. (CV) is trading at US$6.19, down 7.61% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$301.28M. Over the past 52 weeks, CV has traded between US$4.34 and US$15.37. On Syfe you can trade CV with $0 commission and add it to your watchlist.
| Previous close | US$6.70 |
|---|---|
| Market cap | US$301.28M |
| 52-week range | US$4.34 – US$15.37 |
| Volume | 170.6K |
| Exchange | US |
Add to Watchlist
Set Price Alert
CapsoVision, Inc.
CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.
Year: 2025
CapsoVision Files Mixed Shelf for Up to $250 Million in Securities
Aug 13, 9:18 PM · MT Newswires
CapsoVision, Inc. (CV) stock is trading at US$6.19, -7.61% from the previous close of US$6.70.
The market cap for CapsoVision, Inc. (CV) stock is approximately US$301.28M.
The 52-week high for CapsoVision, Inc. (CV) stock is US$15.37.
The 52-week low for CapsoVision, Inc. (CV) stock is US$4.34.
CapsoVision, Inc. (CV) does not currently pay a dividend.
Stay on top of CV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
